内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Longeveron Inc.

LGVN · Nasdaq · CIK 0001721484 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

28 同一窗口内观察到的 Form 4 交易行
0 sales · 28 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-08-11 · Locklear Lisa · value unavailable

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Lehr Paul TGeneral Counsel, Secretary
○○○○
Blass DevinCTO & SVP of CMC
○○○○
Agafonova NataliyaChief Medical Officer
○○○○
Willard Stephen HChief Executive Officer
○○○
Locklear LisaChief Financial Officer
○○
Hare JoshuaChief Scientific Officer
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-11 · Locklear Lisa.

近期 Form 4 活动

0买入
0卖出
40其他 Form 4 交易行
39SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他28 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
106,796
上期报告
213,777
日均成交量
286,638
回补天数
≤ 1.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-08-11Locklear Lisa买入 (P)Class A Common Stock11,766USD —USD —SEC 申报 ↗
2025-08-11Baluch Khoso买入 (P)Class A Common Stock11,766USD —USD —SEC 申报 ↗
2024-04-11Soffer Rock买入 (P)Class A Common Stock31,915USD 2.35USD 75,000SEC 申报 ↗
2024-04-11Hashad Mohamed Wa'el Ahmed买入 (P)Class A Common Stock10,638USD 2.35USD 24,999SEC 申报 ↗
2024-04-11Hare Joshua买入 (P)Class A Common Stock42,553USD 2.35USD 100,000SEC 申报 ↗
2024-04-10Soffer Rock买入 (P)Class A Common Stock106,383USD 2.35USD 250,000SEC 申报 ↗
2024-04-10Hare Joshua买入 (P)Class A Common Stock106,383USD 2.35USD 250,000SEC 申报 ↗
2024-01-10Ross Cathy买入 (P)Common Stock5,000USD 1.31USD 6,550SEC 申报 ↗
2023-12-29Baluch Khoso买入 (P)Common Stock8,322USD 1.43USD 11,900SEC 申报 ↗
2023-12-28Baluch Khoso买入 (P)Common Stock1,678USD 1.40USD 2,349SEC 申报 ↗
2023-12-28PFEFFER JEFFREY买入 (P)Common Stock10,000USD 1.35USD 13,500SEC 申报 ↗
2021-10-13Green Geoff买入 (P)Common stock1,000USD 3.81USD 3,810SEC 申报 ↗
2021-10-13Soffer Rock买入 (P)Common stock12,000USD 3.76USD 45,120SEC 申报 ↗
2021-10-12Hare Joshua买入 (P)Common stock2,500USD 3.69USD 9,225SEC 申报 ↗
2021-10-12Soffer Rock买入 (P)Common stock4,000USD 3.57USD 14,280SEC 申报 ↗

Form 4 申报证据

40 transaction lines in the latest 365-day window; 214 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-01Willard Stephen H代扣税 (F)Class A Common Stock1,987USD 2.59USD 5,146SEC 申报 ↗
2026-10-01Lehr Paul T代扣税 (F)Class A Common Stock2,253USD 2.59USD 5,835SEC 申报 ↗
2026-10-01Jhaveri Nirav S.代扣税 (F)Class A Common Stock742USD 2.59USD 1,922SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-01Willard Stephen H代扣税 (F)Class A Common Stock1,987USD 2.59USD 5,146SEC 申报 ↗
2026-10-01Lehr Paul T代扣税 (F)Class A Common Stock2,253USD 2.59USD 5,835SEC 申报 ↗
2026-10-01Jhaveri Nirav S.代扣税 (F)Class A Common Stock742USD 2.59USD 1,922SEC 申报 ↗
2026-10-01Blass Devin代扣税 (F)Class A Common Stock2,520USD 2.59USD 6,527SEC 申报 ↗
2026-10-01Agafonova Nataliya代扣税 (F)Class A Common Stock2,913USD 2.59USD 7,545SEC 申报 ↗
2026-08-19Ungaro Ursula奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Soffer Rock奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Paletta George A. Jr.奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Lehr Paul T奖励／授予 (A)Class A Common Stock286,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Hare Joshua奖励／授予 (A)Class A Common Stock286,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Hajjar Roger Joseph奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Desai Arjun JJ奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Cann Leah Rush奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Blass Devin奖励／授予 (A)Class A Common Stock286,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Ascheim Deborah奖励／授予 (A)Class A Common Stock36,000USD 0.00USD 0SEC 申报 ↗
2026-08-19Agafonova Nataliya奖励／授予 (A)Class A Common Stock286,000USD 0.00USD 0SEC 申报 ↗
2026-08-17Jhaveri Nirav S.奖励／授予 (A)Class A Common Stock300,000USD 0.00USD 0SEC 申报 ↗
2026-07-06Hare Joshua奖励／授予 (A)Class B Common Stock600,000USD 0.00USD 0SEC 申报 ↗
2026-07-01Willard Stephen H代扣税 (F)Class A Common Stock18,046USD 0.73USD 13,174SEC 申报 ↗
2026-07-01Locklear Lisa代扣税 (F)Class A Common Stock22,505USD 0.73USD 16,429SEC 申报 ↗
2026-07-01Lehr Paul T代扣税 (F)Class A Common Stock13,143USD 0.73USD 9,594SEC 申报 ↗
2026-07-01Blass Devin代扣税 (F)Class A Common Stock15,808USD 0.73USD 11,540SEC 申报 ↗
2026-07-01Agafonova Nataliya代扣税 (F)Class A Common Stock22,505USD 0.73USD 16,429SEC 申报 ↗
2026-05-01Willard Stephen H奖励／授予 (A)Class A Common Stock500,000USD 0.00USD 0SEC 申报 ↗
2026-05-01Locklear Lisa奖励／授予 (A)Class A Common Stock250,000USD 0.00USD 0SEC 申报 ↗
2026-05-01Lehr Paul T奖励／授予 (A)Class A Common Stock250,000USD 0.00USD 0SEC 申报 ↗
2026-05-01Blass Devin奖励／授予 (A)Class A Common Stock250,000USD 0.00USD 0SEC 申报 ↗
2026-05-01Agafonova Nataliya奖励／授予 (A)Class A Common Stock250,000USD 0.00USD 0SEC 申报 ↗
2026-04-01Willard Stephen H代扣税 (F)Class A Common Stock4,740USD 1.12USD 5,309SEC 申报 ↗
2026-04-01Locklear Lisa代扣税 (F)Class A Common Stock13,145USD 1.12USD 14,722SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码LGVN
CIK0001721484
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史214 transaction lines from 2021-02-11 to 2026-10-01
25 P purchase lines · 17 S sale lines · 172 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.